CA2570956C - Method of using silicon carbide for removal of adventitious agents - Google Patents
Method of using silicon carbide for removal of adventitious agents Download PDFInfo
- Publication number
- CA2570956C CA2570956C CA2570956A CA2570956A CA2570956C CA 2570956 C CA2570956 C CA 2570956C CA 2570956 A CA2570956 A CA 2570956A CA 2570956 A CA2570956 A CA 2570956A CA 2570956 C CA2570956 C CA 2570956C
- Authority
- CA
- Canada
- Prior art keywords
- silicon carbide
- adventitious
- adventitious materials
- fluid
- materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 74
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 title claims abstract description 73
- 229910010271 silicon carbide Inorganic materials 0.000 title claims abstract description 72
- 239000003795 chemical substances by application Substances 0.000 title claims description 41
- 239000002158 endotoxin Substances 0.000 claims abstract description 57
- 239000012530 fluid Substances 0.000 claims abstract description 43
- 239000000463 material Substances 0.000 claims abstract description 42
- 241000700605 Viruses Species 0.000 claims abstract description 38
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 241000894006 Bacteria Species 0.000 claims abstract description 25
- 108091000054 Prion Proteins 0.000 claims abstract description 22
- 102000029797 Prion Human genes 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000002002 slurry Substances 0.000 claims abstract description 17
- 239000000872 buffer Substances 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 238000011282 treatment Methods 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 4
- 239000012501 chromatography medium Substances 0.000 claims description 2
- 108091005461 Nucleic proteins Proteins 0.000 claims 5
- 239000002245 particle Substances 0.000 abstract description 30
- 108090000623 proteins and genes Proteins 0.000 abstract description 23
- 230000008569 process Effects 0.000 abstract description 8
- 239000000243 solution Substances 0.000 description 31
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 17
- 239000000356 contaminant Substances 0.000 description 16
- 238000011013 endotoxin removal Methods 0.000 description 16
- 238000001914 filtration Methods 0.000 description 15
- 239000011347 resin Substances 0.000 description 15
- 229920005989 resin Polymers 0.000 description 15
- 238000004587 chromatography analysis Methods 0.000 description 14
- 239000012528 membrane Substances 0.000 description 12
- 239000012460 protein solution Substances 0.000 description 12
- 230000003612 virological effect Effects 0.000 description 12
- 239000013060 biological fluid Substances 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 102000016943 Muramidase Human genes 0.000 description 7
- 108010014251 Muramidase Proteins 0.000 description 7
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 7
- 239000006166 lysate Substances 0.000 description 7
- 239000004325 lysozyme Substances 0.000 description 7
- 229960000274 lysozyme Drugs 0.000 description 7
- 235000010335 lysozyme Nutrition 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 239000002351 wastewater Substances 0.000 description 4
- IDOQDZANRZQBTP-UHFFFAOYSA-N 2-[2-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=CC=C1OCCO IDOQDZANRZQBTP-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 229920004929 Triton X-114 Polymers 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- VZHLSDPXWXOQRY-UHFFFAOYSA-M 1-benzyl-4-ethenylpyridin-1-ium;bromide Chemical compound [Br-].C1=CC(C=C)=CC=[N+]1CC1=CC=CC=C1 VZHLSDPXWXOQRY-UHFFFAOYSA-M 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 238000002944 PCR assay Methods 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000005571 anion exchange chromatography Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- -1 cellulose Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 229960000789 guanidine hydrochloride Drugs 0.000 description 2
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000012569 microbial contaminant Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108700021402 PrP 27-30 Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 102000007365 Sialoglycoproteins Human genes 0.000 description 1
- 108010032838 Sialoglycoproteins Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000011001 backwashing Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000012504 chromatography matrix Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 108010072542 endotoxin binding proteins Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 238000001597 immobilized metal affinity chromatography Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010935 polish filtration Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/283—Porous sorbents based on silica
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
Abstract
A method of using silicon carbide for removing adventitious materials such as endotoxins, prions, viruses and bacteria from water, buffers, aqueous solutions or biological preparations of DNA or proteins, or any combination thereof. The present invention provides for a method of removing adventitious materials from a fluid by passing the fluid through a column or filter bed comprised of silicon carbide particles, or by passing the fluid through a silicon carbide slurry. The method reduces at least 90% of bacteria and endotoxins. It is an economical, reproducible and regenerable process for removing adventitious materials from various fluids.
Description
METHOD OF USING SILICON CARBIDE FOR REMOVAL OF
ADVENTITIOUS AGENTS
Field of the Invention This invention relates to a method of using silicon carbide for the removal of adventitious agents from fluids.
Background of the Invention There has long been and continues to be a need for effectively removing impurities and adventitious materials, such as viruses, endotoxins, prions and bacteria, from fluids, including biological fluids, to be used for administration to humans or animals. The removal of these adventitious materials is often required for use of such fluids in research and medical procedures. These substances may cause an adverse reaction to the host, and thus standards have been set by regulatory bodies for the acceptable levels of such substances in biological fluids which can not be exceeded.
These fluids can include, but are not limited to, protein solutions, DNA
solutions, buffers and the water used for their preparation. Such biological fluids have applications in human gene therapy, as well as vaccines and other pharmaceuticals.
Similarly, it is important to remove adventitious agents such as viruses, endotoxins, prions and bacteria from water sources. Purified water has many applications from drinking water, to uses in dental and medical offices, to the production of various pharmaceutical-grade protein and DNA solutions used in research and medical procedures in humans and animals.
While there are many different separation methods available to remove contaminants from biological fluids and water, chromatography processes and filtration have been the most commonly used. Chromatography has been a long standing method because it allows for the selective removal of contaminants from biological fluids. In general, chromatography allows for the separation of molecules based on differences in their structure and/or composition. It is important, however, that the method of chromatography chosen be effective in removing the adventitious material while leaving the biological of interest (protein or DNA) behind.
The process of filtration refers to forcing a particle-laden liquid through a filter fabric or media of predetermined pore size. The driving force can be gravity, pressure or vacuum. Suspended particles in the feed stream are trapped on the surface of the filter media while the clarified liquid passes through the filter. To function as a filter, media must allow the fluid, commonly water, through while holding back the particulate contaminant. This holding back of the contaminant is accomplished by one or both of two distinctly different filtration mechanisms, namely (1) mechanical straining, and (2) adsorption.
Viral contamination can often be found in biological fluids, and is deemed unacceptable for preparations to be used for administration to humans.
Furthermore, various regulatory agencies have suggested that viruses be reduced in drinking water by 99.99%. A number of different methods have been developed for the removal of various viruses from these liquids. The two main methods involve chromatography with some type of material or resin, and filtration.
Various different types of chromatographic materials have been used for virus removal from liquids. The structure and properties of viruses vary considerably, and thus the resin or material used in the chromatography application for the removal of viruses is often specific for a certain virus or family of viruses. A method for the separation of viruses, including retroviruses and viral vectors, from biological therapeutics is disclosed in U.S. Pat. No. 5,447,859. This method relies on the use of sulfated oligosaccharides, including cellulose, to bind and elute the virus.
In U.S. Pat.
No. 4,869,826 cellular adsorbents for the removal of viral contaminants from whole blood and protein solutions are prepared by immobilizing and stabilizing cells or portions of cellular receptors for the target contaminants. The viruses are then removed by the affinity binding of the viral proteins of the contaminants and their corresponding immobilized cellular receptors.
A number of other substances have been found successful in the removal of viruses from biological fluids. Cross-linked poly (N-benzyl-4-vinylpyridinium bromide) (BVP resin) was found to be efficient in removing pathogenic human viruses from aqueous solutions (Kawabata et al., 1990). Oxidized coals have been found successful in removing coliphages and waterborne human enteric viruses from seeded water sources (Cloete et al., 1998). Chromatographic removal of hepatitis A
virus during the manufacture of human albumin was demonstrated using DEAE-Sepharose(R) Fast Flow and CM-Sepharose (R) Fast Flow (Adcock et al., 1998).
ADVENTITIOUS AGENTS
Field of the Invention This invention relates to a method of using silicon carbide for the removal of adventitious agents from fluids.
Background of the Invention There has long been and continues to be a need for effectively removing impurities and adventitious materials, such as viruses, endotoxins, prions and bacteria, from fluids, including biological fluids, to be used for administration to humans or animals. The removal of these adventitious materials is often required for use of such fluids in research and medical procedures. These substances may cause an adverse reaction to the host, and thus standards have been set by regulatory bodies for the acceptable levels of such substances in biological fluids which can not be exceeded.
These fluids can include, but are not limited to, protein solutions, DNA
solutions, buffers and the water used for their preparation. Such biological fluids have applications in human gene therapy, as well as vaccines and other pharmaceuticals.
Similarly, it is important to remove adventitious agents such as viruses, endotoxins, prions and bacteria from water sources. Purified water has many applications from drinking water, to uses in dental and medical offices, to the production of various pharmaceutical-grade protein and DNA solutions used in research and medical procedures in humans and animals.
While there are many different separation methods available to remove contaminants from biological fluids and water, chromatography processes and filtration have been the most commonly used. Chromatography has been a long standing method because it allows for the selective removal of contaminants from biological fluids. In general, chromatography allows for the separation of molecules based on differences in their structure and/or composition. It is important, however, that the method of chromatography chosen be effective in removing the adventitious material while leaving the biological of interest (protein or DNA) behind.
The process of filtration refers to forcing a particle-laden liquid through a filter fabric or media of predetermined pore size. The driving force can be gravity, pressure or vacuum. Suspended particles in the feed stream are trapped on the surface of the filter media while the clarified liquid passes through the filter. To function as a filter, media must allow the fluid, commonly water, through while holding back the particulate contaminant. This holding back of the contaminant is accomplished by one or both of two distinctly different filtration mechanisms, namely (1) mechanical straining, and (2) adsorption.
Viral contamination can often be found in biological fluids, and is deemed unacceptable for preparations to be used for administration to humans.
Furthermore, various regulatory agencies have suggested that viruses be reduced in drinking water by 99.99%. A number of different methods have been developed for the removal of various viruses from these liquids. The two main methods involve chromatography with some type of material or resin, and filtration.
Various different types of chromatographic materials have been used for virus removal from liquids. The structure and properties of viruses vary considerably, and thus the resin or material used in the chromatography application for the removal of viruses is often specific for a certain virus or family of viruses. A method for the separation of viruses, including retroviruses and viral vectors, from biological therapeutics is disclosed in U.S. Pat. No. 5,447,859. This method relies on the use of sulfated oligosaccharides, including cellulose, to bind and elute the virus.
In U.S. Pat.
No. 4,869,826 cellular adsorbents for the removal of viral contaminants from whole blood and protein solutions are prepared by immobilizing and stabilizing cells or portions of cellular receptors for the target contaminants. The viruses are then removed by the affinity binding of the viral proteins of the contaminants and their corresponding immobilized cellular receptors.
A number of other substances have been found successful in the removal of viruses from biological fluids. Cross-linked poly (N-benzyl-4-vinylpyridinium bromide) (BVP resin) was found to be efficient in removing pathogenic human viruses from aqueous solutions (Kawabata et al., 1990). Oxidized coals have been found successful in removing coliphages and waterborne human enteric viruses from seeded water sources (Cloete et al., 1998). Chromatographic removal of hepatitis A
virus during the manufacture of human albumin was demonstrated using DEAE-Sepharose(R) Fast Flow and CM-Sepharose (R) Fast Flow (Adcock et al., 1998).
-2-Thus various chromatographic methods have been developed for the removal of viruses from biological fluids and water.
Filtration is another method that is heavily relied on for the separation of viruses from biological solutions and water. In U.S. Pat. No. 6,110,374 a treatment process for removing microbial contaminants suspended in wastewater is disclosed, which involves adding an agglomerate-promoting agent to the wastewater such that solids aggregate in the volume of wastewater and include the pathogenic organism.
The volume of wastewater is then passed through a filter cloth membrane constructed of random web needled polyester felt, in order to remove the microbial contaminants, including viruses. In U.S. Pat. No. 6,365,395 a two-step filtration process is used to remove protein aggregates and viruses from a protein solution. Other materials have also been used to filter viruses from solutions. Modified diatomaceous earth was used in filters, and was found to adsorb enteroviruses and coliphages (Farrah et al., 1991).
In U.S. Pat. No. 6,783,713 a process is disclosed for forming an activated carbon fiber filter for removing viruses from liquids. Manabe et al (U.S. Pat. No.
4,857,196) developed a novel porous hollow fiber membrane that has been found to be especially useful for the removal of a virus from an aqueous protein solution.
In addition to viral contamination, endotoxin contamination of biological solutions is also a common problem. Plasmid DNA production depends on fermentation processes for the Gram-negative bacterium E. coli, as does the production of many pharmaceuticals. Endotoxins are a class of lipopolysaccharides which are an integral part of the outer membrane of Gram-negative bacteria, and are responsible for their organization and stability. Although the endotoxins are anchored firmly in the cell wall, they are continuously liberated into the environment through cell death, growth and division. Bacterial endotoxins show strong biological effects at very low concentrations in human beings and many animals when entering the blood stream, including sepsis and septic shock, leading to severe hypertension, cardiovascular collapse, multiple organ failure and death. Thus the FDA has deemed them unacceptable in preparations to be administered to humans (Petsch and Anspach, 2000).
There is no generally applicable method for endotoxin removal available.
Ultrafiltration, which is used for water purification, has little effect on low endotoxin
Filtration is another method that is heavily relied on for the separation of viruses from biological solutions and water. In U.S. Pat. No. 6,110,374 a treatment process for removing microbial contaminants suspended in wastewater is disclosed, which involves adding an agglomerate-promoting agent to the wastewater such that solids aggregate in the volume of wastewater and include the pathogenic organism.
The volume of wastewater is then passed through a filter cloth membrane constructed of random web needled polyester felt, in order to remove the microbial contaminants, including viruses. In U.S. Pat. No. 6,365,395 a two-step filtration process is used to remove protein aggregates and viruses from a protein solution. Other materials have also been used to filter viruses from solutions. Modified diatomaceous earth was used in filters, and was found to adsorb enteroviruses and coliphages (Farrah et al., 1991).
In U.S. Pat. No. 6,783,713 a process is disclosed for forming an activated carbon fiber filter for removing viruses from liquids. Manabe et al (U.S. Pat. No.
4,857,196) developed a novel porous hollow fiber membrane that has been found to be especially useful for the removal of a virus from an aqueous protein solution.
In addition to viral contamination, endotoxin contamination of biological solutions is also a common problem. Plasmid DNA production depends on fermentation processes for the Gram-negative bacterium E. coli, as does the production of many pharmaceuticals. Endotoxins are a class of lipopolysaccharides which are an integral part of the outer membrane of Gram-negative bacteria, and are responsible for their organization and stability. Although the endotoxins are anchored firmly in the cell wall, they are continuously liberated into the environment through cell death, growth and division. Bacterial endotoxins show strong biological effects at very low concentrations in human beings and many animals when entering the blood stream, including sepsis and septic shock, leading to severe hypertension, cardiovascular collapse, multiple organ failure and death. Thus the FDA has deemed them unacceptable in preparations to be administered to humans (Petsch and Anspach, 2000).
There is no generally applicable method for endotoxin removal available.
Ultrafiltration, which is used for water purification, has little effect on low endotoxin
-3-levels present in protein solutions. Thus, there have been many methods developed, including ion-exchangers, two-phase extraction and affinity techniques, as well as tailor-made endotoxin-selective adsorber matrices for endotoxin removal (Anspach, 2001). For research purposes, multiple CsCl banding of plasmid DNA has been used as a method for removing endotoxins. However, this method does not completely remove endotoxins, and it is time-consuming and uses a number of toxic substances.
As stated, ultrafiltration has been used for the removal of endotoxins from water and other solutions (Li and Lou, 1989, Li and Lou, 1999).
Ultrafiltration using membranes with about 10 kDa nominal-molecular-weight cutoff is routinely employed to obtain ultrapure water in laboratory systems (Petsch and Anspach, 2000).
An ultrafiltration device has also been found effective in reducing endotoxin concentrations in bicarbonate dialysis fluids (Loiver et al., 1992). In U.S.
Pat. No.
5,221,483 a single filtration device containing coated filter membranes and absolute pore filters is disclosed that is used to remove endotoxins and viruses. A
filter and filter device for endotoxin removal is disclosed in U.S. Pat. No. 6,849,185.
The use of ion-exchangers and affinity adsorbers is the most wide-spread method of endotoxin removal and reduction. In U.S. Patent No. 6,194,562 a method for endotoxin removal from nucleic acids, such as RNA, DNA or hybrids thereof is described. The method relies on removing endotoxins from solutions using silica-based materials, such as silica gel particles, magnetic silica particles, or diatomaceous earth. In U.S. Patent No. 6,365,147 endotoxin removal from biological solutions is described using an immobilized metal affinity chromatography matrix composed of a metal such as iron, bound to a resin, wherein the metal is capable of selectively binding endotoxin in the solution. In U.S. Patent Nos. 5,747,663 and 6,669,386 endotoxin removal using different chromatographic materials is described. A
method for removing endotoxins from nucleic acids, by pre-incubating the nucleic acids in a salt-free detergent solution and subsequent anion exchange chromatography on a tentacle anion exchanger is disclosed in U.S. Patent No. 6,617,443.
Furthermore, a method for the removal of endotoxins from potable water has been described in U.S.
Patent No. 6,106,723. This method produces ultrapure water to meet the needs of hemodialysis and other biological applications. In this method, source water is processed by a combination of membrane and chromatographic methods including
As stated, ultrafiltration has been used for the removal of endotoxins from water and other solutions (Li and Lou, 1989, Li and Lou, 1999).
Ultrafiltration using membranes with about 10 kDa nominal-molecular-weight cutoff is routinely employed to obtain ultrapure water in laboratory systems (Petsch and Anspach, 2000).
An ultrafiltration device has also been found effective in reducing endotoxin concentrations in bicarbonate dialysis fluids (Loiver et al., 1992). In U.S.
Pat. No.
5,221,483 a single filtration device containing coated filter membranes and absolute pore filters is disclosed that is used to remove endotoxins and viruses. A
filter and filter device for endotoxin removal is disclosed in U.S. Pat. No. 6,849,185.
The use of ion-exchangers and affinity adsorbers is the most wide-spread method of endotoxin removal and reduction. In U.S. Patent No. 6,194,562 a method for endotoxin removal from nucleic acids, such as RNA, DNA or hybrids thereof is described. The method relies on removing endotoxins from solutions using silica-based materials, such as silica gel particles, magnetic silica particles, or diatomaceous earth. In U.S. Patent No. 6,365,147 endotoxin removal from biological solutions is described using an immobilized metal affinity chromatography matrix composed of a metal such as iron, bound to a resin, wherein the metal is capable of selectively binding endotoxin in the solution. In U.S. Patent Nos. 5,747,663 and 6,669,386 endotoxin removal using different chromatographic materials is described. A
method for removing endotoxins from nucleic acids, by pre-incubating the nucleic acids in a salt-free detergent solution and subsequent anion exchange chromatography on a tentacle anion exchanger is disclosed in U.S. Patent No. 6,617,443.
Furthermore, a method for the removal of endotoxins from potable water has been described in U.S.
Patent No. 6,106,723. This method produces ultrapure water to meet the needs of hemodialysis and other biological applications. In this method, source water is processed by a combination of membrane and chromatographic methods including
-4-reverse osmosis, ion exchange deionization, endotoxin-specific adsorption steps and polishing filtration to reduce contamination levels below those specified by the FDA
(the U.S. Food and Drug Administration).
Affinity adsoption relying on various molecules has also been employed for endotoxin removal. Polymyxin B has shown good clearance of endotoxin (Issekutz, 1983), and has been used in various forms including immobilized on Sepharose (Karpus et al., 1987), with membrane support (Petsch et al., 1997), and with fiber support (Tant et al., 1992). The use of immobilized histidine has also met with varying success, with the histidine being immobilized with Sepharose resin support (Matsumae et al., 1990), with filter-paper support (Gao et al., 1997), or with hollow fiber membrane support (Legallis et al., 1997). Other chromatographic methods have included the use of deoxycholic acid, polycationic ligands (PEI, PLL, PLH), as well as polymeric matrices with cationic functional groups such as spherical porous poly (y-methyl-L-glutamate) beads (Anspach, 2001).
A novel method for endotoxin removal has been developed by Wainwright and Novitsky, and involves the use of endotoxin binding/neutralizing proteins capable of binding endotoxin in vivo, thereby neutralizing the toxic effect or bioactivity of endotoxin (U.S. Patent Nos. 5,747,455, 6,222,021, 6,384,200). Thus, there are clearly numerous methods that can be used to remove endotoxins from biological fluids, and the method to be used depends on the fluid in question.
The removal of prions from solutions to be used in biological applications is also very important. Prions are infectious agents composed exclusively of a single sialoglycoprotein called PrP 27-30. They contain no nucleic acid, and cause a number of neurodegenerative diseases in humans. There are currently very few methods for the removal of prions from biological solutions. Traditional methods for treating prions have involved their inactivation, typically by heating to temperatures higher than 130 C and treatment with concentrated sodium hydroxide solution. Other methods of lowering prion activity include treatment with organic solvents, detergents, protein-denaturing agents, chaotropic salts and phenol. However, these methods cannot be applied to most biological solutions as such high heat and harsh treatment will lead to the denaturation and destruction of the biological of interest.
(the U.S. Food and Drug Administration).
Affinity adsoption relying on various molecules has also been employed for endotoxin removal. Polymyxin B has shown good clearance of endotoxin (Issekutz, 1983), and has been used in various forms including immobilized on Sepharose (Karpus et al., 1987), with membrane support (Petsch et al., 1997), and with fiber support (Tant et al., 1992). The use of immobilized histidine has also met with varying success, with the histidine being immobilized with Sepharose resin support (Matsumae et al., 1990), with filter-paper support (Gao et al., 1997), or with hollow fiber membrane support (Legallis et al., 1997). Other chromatographic methods have included the use of deoxycholic acid, polycationic ligands (PEI, PLL, PLH), as well as polymeric matrices with cationic functional groups such as spherical porous poly (y-methyl-L-glutamate) beads (Anspach, 2001).
A novel method for endotoxin removal has been developed by Wainwright and Novitsky, and involves the use of endotoxin binding/neutralizing proteins capable of binding endotoxin in vivo, thereby neutralizing the toxic effect or bioactivity of endotoxin (U.S. Patent Nos. 5,747,455, 6,222,021, 6,384,200). Thus, there are clearly numerous methods that can be used to remove endotoxins from biological fluids, and the method to be used depends on the fluid in question.
The removal of prions from solutions to be used in biological applications is also very important. Prions are infectious agents composed exclusively of a single sialoglycoprotein called PrP 27-30. They contain no nucleic acid, and cause a number of neurodegenerative diseases in humans. There are currently very few methods for the removal of prions from biological solutions. Traditional methods for treating prions have involved their inactivation, typically by heating to temperatures higher than 130 C and treatment with concentrated sodium hydroxide solution. Other methods of lowering prion activity include treatment with organic solvents, detergents, protein-denaturing agents, chaotropic salts and phenol. However, these methods cannot be applied to most biological solutions as such high heat and harsh treatment will lead to the denaturation and destruction of the biological of interest.
-5-There are very few patents that deal with the removal of prions from biological solutions. In U.S. Patent No. 5,808,011 the removal of prions from a solution containing the prion and at least one other biomolecule is disclosed that involves directing the solution through an anion-exchange chromatography column under conditions that cause a gradient elution, whereby the prion is separated by eluting in a different fraction than the biomolecule. In U.S. Patent No. 6,372,510 prions are removed from aqueous protein solutions by treating the solution with simultaneous electrostatic adsorption and hydrophobic chromatography.
The same methods that are used for the removal of viruses could in theory also be used for the removal of prions, including filtration, selective adsorption, and chromatography. The transmissible character of prions is very powerful, and no chromatographic methods are currently available that are known to remove, with certainty, the last traces which may contaminate complex biological solutions.
Filtration methods have been suggested for this purpose, but the size of pores selected to stop prions also stops large proteins, because either the protein has a diameter that is greater than that of the pore or because adsorption phenomena complicate filtration of the protein. Thus there are a number of problems with the current methods for prion removal.
Bacterial contamination in biological fluids and water is also a problem.
Traditionally, the removal of bacteria has been accomplished by filtration, including microfiltration and membrane filtration. Regulatory agencies have set forth minimum standards for the amount of bacteria that is acceptable in drinking water, and currently 99.999% must be removed. A few novel methods have been developed for the removal of bacteria from aqueous solutions. In U.S. Patent No. 5,432,077 methods for the removal of impurities from aqueous materials by contact with an adsorptive product are disclosed. And in U.S. Patent No. 5,242,595 bacterial removal by passing a bacteria-containing liquid through a plural-coated-sintered inorganic membrane on a larger pore size inorganic ceramic support is disclosed.
A significant benefit for the removal of adventitious agents would be a single device capable of removing more than one type of contaminant. In U.S. Patent No.
4,791,063 a polyionene-transformed modified polymer-polysaccharide separation matrix is disclosed that can be used to remove various contaminants of microorganism
The same methods that are used for the removal of viruses could in theory also be used for the removal of prions, including filtration, selective adsorption, and chromatography. The transmissible character of prions is very powerful, and no chromatographic methods are currently available that are known to remove, with certainty, the last traces which may contaminate complex biological solutions.
Filtration methods have been suggested for this purpose, but the size of pores selected to stop prions also stops large proteins, because either the protein has a diameter that is greater than that of the pore or because adsorption phenomena complicate filtration of the protein. Thus there are a number of problems with the current methods for prion removal.
Bacterial contamination in biological fluids and water is also a problem.
Traditionally, the removal of bacteria has been accomplished by filtration, including microfiltration and membrane filtration. Regulatory agencies have set forth minimum standards for the amount of bacteria that is acceptable in drinking water, and currently 99.999% must be removed. A few novel methods have been developed for the removal of bacteria from aqueous solutions. In U.S. Patent No. 5,432,077 methods for the removal of impurities from aqueous materials by contact with an adsorptive product are disclosed. And in U.S. Patent No. 5,242,595 bacterial removal by passing a bacteria-containing liquid through a plural-coated-sintered inorganic membrane on a larger pore size inorganic ceramic support is disclosed.
A significant benefit for the removal of adventitious agents would be a single device capable of removing more than one type of contaminant. In U.S. Patent No.
4,791,063 a polyionene-transformed modified polymer-polysaccharide separation matrix is disclosed that can be used to remove various contaminants of microorganism
-6-origin from biological liquids. In U.S. Patent No. 6,827,854 a filter and filter materials for removing microorganisms from a fluid are provided. And in U.S.
Patent No. 6,838,005 aluminum hydroxide fibers are used in a filter with other fibers or particles, and the filter is shown to filter bacteria and viruses at high flux. These methods all have the benefit that they are capable of removing multiple types of contaminants.
There are a number of problems with the current known methods for removal of contaminants from biological fluids. Often times, the contaminant removal efficiency of some of the current membranes is limited because the binding capacity of the contaminant is low, and this leads to early breakthough of the contaminant into the filtered fluid. Some of the methods employed for contaminant removal, particularly for endotoxin removal, are difficult to employ successfully in industry because of the very small amount of occurring contaminant. Additional problems with chromatography include the fact that it is often difficult for proteins and larger biomolecules to diffuse through the narrow pores, excessive binding and distortion of the protein structure may occur, and the matrix is often hydrophobic and can cause denaturation of the proteins. Furthermore, non-specific adsorption often occurs and can lead to the loss of the biological of interest.
Problems encountered with filtration include the buildup of slime on the filter and the filter becoming clogged, particularly during the filtration of bacteria. Due to the small pore size of nanofilters, it is often difficult to filter biological liquids through a nanofilter. Furthermore, it has been found with the filtration of viruses that the filters are generally not absolute filters, and the passage of small viruses through the filter frequently occurs. This may be due to pressure being applied to the filter and the filter subsequently breaking, or the virus may change in size due to the sheer force and thus pass though the membrane.
As a result, the demand for reproducible, controllable, and rapid processes for the removal of viruses, endotoxins, prions and bacteria from water, buffers, solutions, and biological preparations of DNA or proteins has persisted. Further, it is desirable that such processes be inexpensive, allow for the inactivation of the adventitious agent and be regenerable.
Patent No. 6,838,005 aluminum hydroxide fibers are used in a filter with other fibers or particles, and the filter is shown to filter bacteria and viruses at high flux. These methods all have the benefit that they are capable of removing multiple types of contaminants.
There are a number of problems with the current known methods for removal of contaminants from biological fluids. Often times, the contaminant removal efficiency of some of the current membranes is limited because the binding capacity of the contaminant is low, and this leads to early breakthough of the contaminant into the filtered fluid. Some of the methods employed for contaminant removal, particularly for endotoxin removal, are difficult to employ successfully in industry because of the very small amount of occurring contaminant. Additional problems with chromatography include the fact that it is often difficult for proteins and larger biomolecules to diffuse through the narrow pores, excessive binding and distortion of the protein structure may occur, and the matrix is often hydrophobic and can cause denaturation of the proteins. Furthermore, non-specific adsorption often occurs and can lead to the loss of the biological of interest.
Problems encountered with filtration include the buildup of slime on the filter and the filter becoming clogged, particularly during the filtration of bacteria. Due to the small pore size of nanofilters, it is often difficult to filter biological liquids through a nanofilter. Furthermore, it has been found with the filtration of viruses that the filters are generally not absolute filters, and the passage of small viruses through the filter frequently occurs. This may be due to pressure being applied to the filter and the filter subsequently breaking, or the virus may change in size due to the sheer force and thus pass though the membrane.
As a result, the demand for reproducible, controllable, and rapid processes for the removal of viruses, endotoxins, prions and bacteria from water, buffers, solutions, and biological preparations of DNA or proteins has persisted. Further, it is desirable that such processes be inexpensive, allow for the inactivation of the adventitious agent and be regenerable.
-7-Brief Description of the Drawings In drawings which illustrate by way of example only a preferred embodiment of the invention, Figure 1 is a graph depicting endotoxin removal from 35 g lysozyme samples spiked with endotoxin using silicon carbide columns and isopropanol as an emulsifier;
Figure 2 is a graph depicting endotoxin removal from 50 g BSA samples spiked with endotoxin using silicon carbide columns with isopropanol and Tritori X-114.
Figure 3 is a graph depicting endotoxin removal from bacterial lysate using silicon carbide columns in the presence of 1% Tritori X-114 and increasing amounts of isopropanol;
Figure 4 is an agarose gel depicting removal of adenovirus d1309 from a PBS buffer using a silicon carbide column by showing the PCR detection of a 470 bp region located in the E1 region of the virus;
Figure 5 is a graph showing the number of viable cells present in the flow through after passing increasing amounts of bacterial cells through a silicon carbide column; and Figure 6 is a graph depicting bacterial removal from a suspension of bacterial cells using a slurry containing 1 gram of silicon carbide.
Detailed Description of the Invention The present invention provides for a method of removing adventitious materials from a fluid by passing the fluid through a column or filter bed comprised of silicon carbide particles, or through mixing the fluid with a silicon carbide slurry. In particular, the present invention provides an economical, reproducible and regenerable process for the removal of viruses, endotoxins, prions and bacteria from water,
Figure 2 is a graph depicting endotoxin removal from 50 g BSA samples spiked with endotoxin using silicon carbide columns with isopropanol and Tritori X-114.
Figure 3 is a graph depicting endotoxin removal from bacterial lysate using silicon carbide columns in the presence of 1% Tritori X-114 and increasing amounts of isopropanol;
Figure 4 is an agarose gel depicting removal of adenovirus d1309 from a PBS buffer using a silicon carbide column by showing the PCR detection of a 470 bp region located in the E1 region of the virus;
Figure 5 is a graph showing the number of viable cells present in the flow through after passing increasing amounts of bacterial cells through a silicon carbide column; and Figure 6 is a graph depicting bacterial removal from a suspension of bacterial cells using a slurry containing 1 gram of silicon carbide.
Detailed Description of the Invention The present invention provides for a method of removing adventitious materials from a fluid by passing the fluid through a column or filter bed comprised of silicon carbide particles, or through mixing the fluid with a silicon carbide slurry. In particular, the present invention provides an economical, reproducible and regenerable process for the removal of viruses, endotoxins, prions and bacteria from water,
-8-buffers, solutions, and biological preparations of DNA and proteins based on the use of silicon carbide, preferably commercially available industrial quality silicon carbide.
A typical industrial preparation of silicon carbide (SiC) which is applicable for use in removal of adventitious agents is composed of 97.8% silicon carbide and small amounts of silicon dioxide, silicon, iron, aluminum and carbon. This substance is affordable and readily available to be used in a column, a filter, or as a slurry for adventitious agent removal. Silicon carbide is available in a variety of grit sizes or grades, and each grade has a different average particle size. Any grade of SiC
can be used in the method according to the present invention, with a preferred grit size for the 1o columns being 2500. The preferred grade will depend on whether it is being used in a small spin column, a large column, a filter or a slurry.
Silicon carbide offers a number of key benefits when used as a column chromatography media, filtration media or slurry for the removal of adventitious agents. First of all, silicon carbide is chemically inert, and thus will be non-reactive with any substances that may be present in the solution, including proteins or DNA.
Furthermore, because it is non-biodegradable, there will be no leaching of the silicon carbide into the purified fluid. Silicon carbide has also been found to be extremely stable in both acid and base treatments, as well as heat. Silicon carbide is also incompressible, thus pressure across the filter or column will not build up because of compression. Another benefit that silicon carbide offers is that it can be cleaned and re-used, thus making it environmentally friendly. In order to clean and regenerate the resin, a combination of washing and elution steps must be performed.
Backwashing may be employed to loosen and remove any mechanically retained substances, while washing and elution will be used to remove any substances which have become absorbed to the silicon carbide. These recovered adventitious agents can then be inactivated through various methods including chemical treatment, such as washing the resin with a strong acid followed by washing with a strong base. Lastly, the silicon carbide columns, filters and slurry with bound adventitious agents can be autoclaved in order to inactivate the adventitious agents through the use of high temperature and high pressure.
In an embodiment of the present invention, there is provided a method for the removal of adventitious materials from fluids, by passing the fluids through a column
A typical industrial preparation of silicon carbide (SiC) which is applicable for use in removal of adventitious agents is composed of 97.8% silicon carbide and small amounts of silicon dioxide, silicon, iron, aluminum and carbon. This substance is affordable and readily available to be used in a column, a filter, or as a slurry for adventitious agent removal. Silicon carbide is available in a variety of grit sizes or grades, and each grade has a different average particle size. Any grade of SiC
can be used in the method according to the present invention, with a preferred grit size for the 1o columns being 2500. The preferred grade will depend on whether it is being used in a small spin column, a large column, a filter or a slurry.
Silicon carbide offers a number of key benefits when used as a column chromatography media, filtration media or slurry for the removal of adventitious agents. First of all, silicon carbide is chemically inert, and thus will be non-reactive with any substances that may be present in the solution, including proteins or DNA.
Furthermore, because it is non-biodegradable, there will be no leaching of the silicon carbide into the purified fluid. Silicon carbide has also been found to be extremely stable in both acid and base treatments, as well as heat. Silicon carbide is also incompressible, thus pressure across the filter or column will not build up because of compression. Another benefit that silicon carbide offers is that it can be cleaned and re-used, thus making it environmentally friendly. In order to clean and regenerate the resin, a combination of washing and elution steps must be performed.
Backwashing may be employed to loosen and remove any mechanically retained substances, while washing and elution will be used to remove any substances which have become absorbed to the silicon carbide. These recovered adventitious agents can then be inactivated through various methods including chemical treatment, such as washing the resin with a strong acid followed by washing with a strong base. Lastly, the silicon carbide columns, filters and slurry with bound adventitious agents can be autoclaved in order to inactivate the adventitious agents through the use of high temperature and high pressure.
In an embodiment of the present invention, there is provided a method for the removal of adventitious materials from fluids, by passing the fluids through a column
-9-packed with particles of silicon carbide, such that the adventitious agent binds to the column and the fluid that passes through the column can be collected and used in other applications. Alternatively, the molecule of interest may bind to the resin in the column while the adventitious agent flows through, and the molecule of interest can then be eluted from the resin into a desired fluid to be used in other applications. The columns can be made in various sizes, from small spin columns all the way to large chromatography columns operating through the use of gravity or pumps. Once bound to the silicon carbide, the adventitious agents can then be inactivated through treating the column with heat, such as autoclaving the column at 120 C for 30 minutes, or through the use of chemical treatments. Chemical tratements to inactivate the adventitous agent could include washing the column with the bound adventitious agent with 1 bed volume of 1 M HCI, followed by washing with 1 bed volume of 1 M
NaOH. Alternatively, if the adventitious agent was removed from the column in the flowthrough, the flowthrough may be treated with heat or chemicals in order to inactivate the adventitious agent. A secondary objective of the exemplary methods was the regeneration of the column by passing a liquid or liquids through the column for the purpose of removing and recovering the adventitious agent for inactivation, and simultaneously regenerating the column.
In another embodiment of the present invention, there is provided a method for the removal of adventitious materials from fluids, by passing the fluids through a filter bed of silicon carbide particles such that the fluid that passes through the filter can be collected and used in other applications. The filter can be used as a cake filter, a pressure filter, a vacuum filter, a deep bed filter or a surface filter. The liquid containing the adventitous agent can be passed through the filter by gravitational force or mechanical means. The adventitious agents can then be inactivated through treating the filter with heat or chemicals. The filter may also be regenerated, by passing liquids through the filter for the purpose of removing and recovering the adventitious agent for inactivation and simultaneously regenerating the column.
In one embodiment of the invention the first step is the generation of the column containing SiC. A silicon carbide slurry for packing in a column can be prepared according to the following description: A 50% weight/volume (w/v) slurry of silicon carbide is prepared in 0.1 M guanidine hydrochloride with constant mixing
NaOH. Alternatively, if the adventitious agent was removed from the column in the flowthrough, the flowthrough may be treated with heat or chemicals in order to inactivate the adventitious agent. A secondary objective of the exemplary methods was the regeneration of the column by passing a liquid or liquids through the column for the purpose of removing and recovering the adventitious agent for inactivation, and simultaneously regenerating the column.
In another embodiment of the present invention, there is provided a method for the removal of adventitious materials from fluids, by passing the fluids through a filter bed of silicon carbide particles such that the fluid that passes through the filter can be collected and used in other applications. The filter can be used as a cake filter, a pressure filter, a vacuum filter, a deep bed filter or a surface filter. The liquid containing the adventitous agent can be passed through the filter by gravitational force or mechanical means. The adventitious agents can then be inactivated through treating the filter with heat or chemicals. The filter may also be regenerated, by passing liquids through the filter for the purpose of removing and recovering the adventitious agent for inactivation and simultaneously regenerating the column.
In one embodiment of the invention the first step is the generation of the column containing SiC. A silicon carbide slurry for packing in a column can be prepared according to the following description: A 50% weight/volume (w/v) slurry of silicon carbide is prepared in 0.1 M guanidine hydrochloride with constant mixing
-10-for 20 minutes. The slurry can then be packed into small polypropylene columns, which have been fitted with a membrane sandwiched between 2 fiber filters.
Generally, either 25 or 50 mg of resin is packed into each spin column, and the columns are then spun down in order to properly pack the resin. Lastly, a top frit is placed over the resin bed which is generally between 0.2 and 0.45 microns.
In general, the binding or removal of each adventitious agent from a fluid using the silicon carbide column will be slightly different, depending on the adventitious agent to be removed and the presence of other substances in the fluid.
Each situation requires extensive testing in order to remove the agent of interest while leaving behind the components of the fluid that are to be used in other applications. In some cases, pre-treatment of the fluid containing the adventitious agent is required. In other cases, different types of silicon carbide that have undergone various treatments are required. In still other cases, various wash or binding solutions will be required.
If there is simply an adventitious agent that is to be removed from either water or a buffer solution, generally the solution will be passed through the column under conditions wherein the agent will bind to the column while the purified liquid will flowthrough and be collected. The column can then either be chemically treated or autoclaved in order to destroy the agent. Alternatively a solution can be passed through the column such that the agent is eluted and can be inactivated, and the column is simultaneously regenerated such that it can be used again.
In the situation where the adventitious agent is present in a solution with DNA
or proteins, the general strategy would proceed in one of two ways. In the first case, the binding conditions for the column would be chosen such that the adventitious agent would bind to the column while the protein or DNA of interest would flowthrough the column in the fluid. In this case, the fluid could be used in other applications, and the adventitious agent would either be inactivated on the column, or a solution could be passed through the column such that the adventitious agent is eluted and can be inactivated, simultaneously regenerating the column. In the second strategy, the protein or DNA of interest would bind to the column while the adventitious agent would pass through into the flowthrough. The DNA or protein of interest could then be eluted into a clean solution and used in other applications, and the adventitious agent could be inactivated through either heat or chemicals.
Generally, either 25 or 50 mg of resin is packed into each spin column, and the columns are then spun down in order to properly pack the resin. Lastly, a top frit is placed over the resin bed which is generally between 0.2 and 0.45 microns.
In general, the binding or removal of each adventitious agent from a fluid using the silicon carbide column will be slightly different, depending on the adventitious agent to be removed and the presence of other substances in the fluid.
Each situation requires extensive testing in order to remove the agent of interest while leaving behind the components of the fluid that are to be used in other applications. In some cases, pre-treatment of the fluid containing the adventitious agent is required. In other cases, different types of silicon carbide that have undergone various treatments are required. In still other cases, various wash or binding solutions will be required.
If there is simply an adventitious agent that is to be removed from either water or a buffer solution, generally the solution will be passed through the column under conditions wherein the agent will bind to the column while the purified liquid will flowthrough and be collected. The column can then either be chemically treated or autoclaved in order to destroy the agent. Alternatively a solution can be passed through the column such that the agent is eluted and can be inactivated, and the column is simultaneously regenerated such that it can be used again.
In the situation where the adventitious agent is present in a solution with DNA
or proteins, the general strategy would proceed in one of two ways. In the first case, the binding conditions for the column would be chosen such that the adventitious agent would bind to the column while the protein or DNA of interest would flowthrough the column in the fluid. In this case, the fluid could be used in other applications, and the adventitious agent would either be inactivated on the column, or a solution could be passed through the column such that the adventitious agent is eluted and can be inactivated, simultaneously regenerating the column. In the second strategy, the protein or DNA of interest would bind to the column while the adventitious agent would pass through into the flowthrough. The DNA or protein of interest could then be eluted into a clean solution and used in other applications, and the adventitious agent could be inactivated through either heat or chemicals.
-11-In one embodiment of the present invention, endotoxins were removed from a protein solution using a 25 mg silicon carbide spin column that was prepared as described above. In this case, samples containing 35 g of lysozyme were spiked with increasing amounts of endotoxin (0.2, 0.6 and 1.0 EU/mL). EU stands for Endotoxin Unit. These samples were then brought up to 175 L with Tris buffer such that the final concentration of the buffer was 25 mM, and the pH was neutral. Equal volumes of the emulsifier, isopropanol, were then added to the sample, bringing the volume to 350 L. These samples were then loaded onto the column by spinning the column for one minute at 14,000 x g. At this point, the proteins will bind to the silicon carbide particles in the column while the endotoxins will flowthrough. The columns with bound protein were then washed with a solution containing the Tris buffer and isopropanol, and lastly the lysozyme samples were eluted using 50 L of 50 mM
sodium phosphate, pH 12.5. By using the isopropanol in the binding and wash steps, up to 96% of the endotoxins were found to be removed. Furthermore, the recovery of the lysozyme was still high. Thus, endotoxins can be removed from a protein solution using a column packed with silicon carbide particles, without compromising protein recovery.
Figure 1 is a graph depicting endotoxin removal from 35 g lysozyme samples spiked with endotoxin using isopropanol as an emulsifier. Endotoxin was removed by passing the protein solution through a silicon carbide column. EC is the endotoxin control, LC is the lysozyme control, and 1, 0.6, and 0.2 correspond to the EU/mL of endotoxin that were used to spike the lysozyme samples prior to loading onto the column.
In another embodiment of the present invention, endotoxins were again removed from protein solutions using a 25 mg silicon carbide spin column that was prepared as described above. In this case, three samples containing 50 g of BSA
were spiked with 87.5 EU of endotoxin each. The samples were then brought up to 500 L with water. Next, 20 pL of a solution containing 0.8333M of phosporic acid, citric acid and sodium hydroxide was added to the samples, and 5 L of Triton X-114 was added to a final concentration of 1%. The samples were then mixed, and L of isopropanol was added to the samples. The samples were loaded onto silicon
sodium phosphate, pH 12.5. By using the isopropanol in the binding and wash steps, up to 96% of the endotoxins were found to be removed. Furthermore, the recovery of the lysozyme was still high. Thus, endotoxins can be removed from a protein solution using a column packed with silicon carbide particles, without compromising protein recovery.
Figure 1 is a graph depicting endotoxin removal from 35 g lysozyme samples spiked with endotoxin using isopropanol as an emulsifier. Endotoxin was removed by passing the protein solution through a silicon carbide column. EC is the endotoxin control, LC is the lysozyme control, and 1, 0.6, and 0.2 correspond to the EU/mL of endotoxin that were used to spike the lysozyme samples prior to loading onto the column.
In another embodiment of the present invention, endotoxins were again removed from protein solutions using a 25 mg silicon carbide spin column that was prepared as described above. In this case, three samples containing 50 g of BSA
were spiked with 87.5 EU of endotoxin each. The samples were then brought up to 500 L with water. Next, 20 pL of a solution containing 0.8333M of phosporic acid, citric acid and sodium hydroxide was added to the samples, and 5 L of Triton X-114 was added to a final concentration of 1%. The samples were then mixed, and L of isopropanol was added to the samples. The samples were loaded onto silicon
-12-carbide columns that had been previously activated through 2 washes with 500 L of 12.5 mM phosphoric acid, 12.5 mM citric acid, and 22.5 mM sodium hydroxide.
The endotoxins flowed through the column, while the BSA was preferentially bound to the silicon carbide. The columns were then washed twice with 500 L of the same phosphoric acid solution. The BSA samples were eluted using 50 L of 10 mM
sodium phosphate, pH 12.5. The endotoxin levels in the final elutions were determined to be an average of 0.6 EU, with protein recoveries of over 92%.
Thus, endotoxins levels can be reduced by greater than 99% in protein solutions using a column packed with silicon carbide particles without compromising protein recovery.
Figure 2 is a graph depicting endotoxin removal from 50 g BSA samples spiked with endotoxin using isopropanol and Tritori X-114. Endotoxin was removed by passing the protein solution through a silicon carbide column. The first bar indicates the average amount of endotoxin in the inputs, while the second bar indicates the average amount of endotoxin in the outputs after the samples were passed through a silicon carbide spin column.
In another embodiment of the present invention, silicon carbide columns were used to remove endotoxins from a bacterial lysate harboring pUC-based plasmid DNA. The columns were prepared as described above, using 25 mg of silicon carbide. In this case, the columns were first equilibrated by passing 400 L
of 0.1 M
guanidine hydrochloride through the columns twice at 14,000 rpm. Triton X-114 was then added to 300 L lysate samples to a final concentration of 1%. These mixtures were allowed to stand for 5 minutes, and then increasing amounts of isopropanol were added to the samples (0, 10, 25 and 50%). The samples were mixed well, and spun down for 5 minutes at 8,000 x g. The clarified lysates were then applied to columns, such that the plasmid DNA could bind while the endotoxins were removed in the flowthrough. The columns were then washed twice with 400 L of TE buffer and ethanol, and the purified plasmid DNA was then eluted using 2 spins of 25 L of TE buffer, pH 11.75. For this particular case, it was found that 10%
isopropanol mixed with 1% Triton X-114 showed the highest removal of endotoxins while maintaining the highest recovery of plasmid DNA. As low as 22 EU/ g of DNA were achieved, compared to 1335 EU/ g for untreated lysate. Thus silicon
The endotoxins flowed through the column, while the BSA was preferentially bound to the silicon carbide. The columns were then washed twice with 500 L of the same phosphoric acid solution. The BSA samples were eluted using 50 L of 10 mM
sodium phosphate, pH 12.5. The endotoxin levels in the final elutions were determined to be an average of 0.6 EU, with protein recoveries of over 92%.
Thus, endotoxins levels can be reduced by greater than 99% in protein solutions using a column packed with silicon carbide particles without compromising protein recovery.
Figure 2 is a graph depicting endotoxin removal from 50 g BSA samples spiked with endotoxin using isopropanol and Tritori X-114. Endotoxin was removed by passing the protein solution through a silicon carbide column. The first bar indicates the average amount of endotoxin in the inputs, while the second bar indicates the average amount of endotoxin in the outputs after the samples were passed through a silicon carbide spin column.
In another embodiment of the present invention, silicon carbide columns were used to remove endotoxins from a bacterial lysate harboring pUC-based plasmid DNA. The columns were prepared as described above, using 25 mg of silicon carbide. In this case, the columns were first equilibrated by passing 400 L
of 0.1 M
guanidine hydrochloride through the columns twice at 14,000 rpm. Triton X-114 was then added to 300 L lysate samples to a final concentration of 1%. These mixtures were allowed to stand for 5 minutes, and then increasing amounts of isopropanol were added to the samples (0, 10, 25 and 50%). The samples were mixed well, and spun down for 5 minutes at 8,000 x g. The clarified lysates were then applied to columns, such that the plasmid DNA could bind while the endotoxins were removed in the flowthrough. The columns were then washed twice with 400 L of TE buffer and ethanol, and the purified plasmid DNA was then eluted using 2 spins of 25 L of TE buffer, pH 11.75. For this particular case, it was found that 10%
isopropanol mixed with 1% Triton X-114 showed the highest removal of endotoxins while maintaining the highest recovery of plasmid DNA. As low as 22 EU/ g of DNA were achieved, compared to 1335 EU/ g for untreated lysate. Thus silicon
-13-carbide columns can be used to remove endotoxins from bacterial lysate when both isopropanol and Tritori X- 114 are used in the sample preparation prior to loading the sample onto the column.
Figure 3 is a graph depicting endotoxin removal from bacterial lysate using silicon carbide columns in the presence of 1% Tritori X-114 and increasing amounts of isopropanol. El corresponds to the first elution, and E2 corresponds to the second elution in each case.
In another embodiment of the preferred invention, columns packed with silicon carbide particles were used to remove adenovirus d1309 from a PBS
buffer.
The columns were prepared as described above. In order to demonstrate viral removal, viral dilutions that contained 1.18 x 10 8 particles, 2.4 x 108 particles, 3.6 x 108 particles, 4.8 x 108 particles, 6.0 x 108 particles and 7.1 x 108 were prepared in PBS buffer in duplicate. One set of the dilutions was passed through 25 mg silicon carbide columns that had been previously activated with 350 L of PBS buffer.
The other set of dilutions were not passed through the columns and were used as controls.
Viral DNA was then isolated from both the column flowthroughs and the controls.
This DNA was used as the template in a PCR assay, which was previously found to be sensitive enough to detect DNA from a single viral particle. It was found that for the samples containing 1.18 - 6.0 x 108 particles, all the virus present was binding to the columns, as no viral DNA could be detected in the flowthrough. However, for the 7.1 x 108 particle sample, viral DNA was indeed detected in the flowthrough, as evidenced by the PCR assay. Thus it could be concluded that a large number of adenoviral particles can be removed from PBS buffer using a silicon carbide column, and that the binding capacity of d1309 for a 25 mg column lies between 6.0 x particles and 7.1 x 108 particles.
Figure 4 shows an agarose gel depicting removal of adenovirus d1309 from a PBS buffer using a silicon carbide column. PCR of a 470 bp region located in the El region of the virus was used to detect the presence of a single virus. Lanes A
and P
correspond to the PCR Sizer Marker, Lanes B and C correspond to 1.18 x 108 viral particles that were not column processed (B) and column processed (C); Lanes D
and E correspond to 2.4 x 10 8 viral particles that were not column processed (D) and column processed (E); Lanes F and G correspond to 3.6 x 108 viral particles that were
Figure 3 is a graph depicting endotoxin removal from bacterial lysate using silicon carbide columns in the presence of 1% Tritori X-114 and increasing amounts of isopropanol. El corresponds to the first elution, and E2 corresponds to the second elution in each case.
In another embodiment of the preferred invention, columns packed with silicon carbide particles were used to remove adenovirus d1309 from a PBS
buffer.
The columns were prepared as described above. In order to demonstrate viral removal, viral dilutions that contained 1.18 x 10 8 particles, 2.4 x 108 particles, 3.6 x 108 particles, 4.8 x 108 particles, 6.0 x 108 particles and 7.1 x 108 were prepared in PBS buffer in duplicate. One set of the dilutions was passed through 25 mg silicon carbide columns that had been previously activated with 350 L of PBS buffer.
The other set of dilutions were not passed through the columns and were used as controls.
Viral DNA was then isolated from both the column flowthroughs and the controls.
This DNA was used as the template in a PCR assay, which was previously found to be sensitive enough to detect DNA from a single viral particle. It was found that for the samples containing 1.18 - 6.0 x 108 particles, all the virus present was binding to the columns, as no viral DNA could be detected in the flowthrough. However, for the 7.1 x 108 particle sample, viral DNA was indeed detected in the flowthrough, as evidenced by the PCR assay. Thus it could be concluded that a large number of adenoviral particles can be removed from PBS buffer using a silicon carbide column, and that the binding capacity of d1309 for a 25 mg column lies between 6.0 x particles and 7.1 x 108 particles.
Figure 4 shows an agarose gel depicting removal of adenovirus d1309 from a PBS buffer using a silicon carbide column. PCR of a 470 bp region located in the El region of the virus was used to detect the presence of a single virus. Lanes A
and P
correspond to the PCR Sizer Marker, Lanes B and C correspond to 1.18 x 108 viral particles that were not column processed (B) and column processed (C); Lanes D
and E correspond to 2.4 x 10 8 viral particles that were not column processed (D) and column processed (E); Lanes F and G correspond to 3.6 x 108 viral particles that were
-14-not column processed (F) and column processed (G); Lanes H and I correspond to 4.8 x 108 viral particles that were not column processed (H) and column processed (I);
Lanes J and K correspond to 6.0 x 10 8 viral particles that were not column processed (J) and column processed (K); Lanes L and M correspond to 7.1 x 108 viral particles that were not column processed (L) and column processed (M). Lane N is a positive control and Lane 0 is a negative control.
In another embodiment of the preferred invention, a silicon carbide column is used to remove bacteria from a liquid. The column is again packed as described above, however it contains a 0.6 micron top frit. In this case, the column is used to remove bacteria from a suspension. A bacterial culture was grown in LB medium, and a viable count of the cells was obtained by colony summation. Dilutions of the culture were then prepared, and applied to the columns by 30 second centrifugation at 14,000 rpm. The flowthrough from the columns was then plated on ampicillin selective agar plates, and a viable cell count was obtained. It was found from this procedure that up to 96% of viable cells were either retained on the column, or were sheared as a result of their passage through the column and their interaction with the sharp particles of silicon carbide. Thus, silicon carbide columns can be used to remove and/or destroy viable bacterial cells from a liquid.
Figure 5 is a graph showing the number of viable cells present in the flowthrough after passing increasing amounts of bacterial cells through a silicon carbide column.
In another embodiment of the preferred invention, a silicon carbide slurry was used to remove bacteria from a liquid, in order to eliminate the sheer stress caused by centrifugation using a column format. Bacterial cells harbouring plasmid DNA
were cultivated to a specific optical density. A viable count of the cells was obtained by colony enumeration, and 10 fold dilutions of cells were applied to separate test tubes that contained lg SiC. The bacterial cells were mixed with the resin by gentle inversion for 30 seconds whereupon the resin was allowed to settle. After 15 minutes of settling, samples were then taken from the test tubes, diluted, and plated onto 3o ampilcillin selective agar plates. A viable count of the cells was then tabulated. It was found that the percentage of cells that were being retained and/or damaged by the resin in some manner is between 92 and 98%. Thus, silicon carbide slurry can be
Lanes J and K correspond to 6.0 x 10 8 viral particles that were not column processed (J) and column processed (K); Lanes L and M correspond to 7.1 x 108 viral particles that were not column processed (L) and column processed (M). Lane N is a positive control and Lane 0 is a negative control.
In another embodiment of the preferred invention, a silicon carbide column is used to remove bacteria from a liquid. The column is again packed as described above, however it contains a 0.6 micron top frit. In this case, the column is used to remove bacteria from a suspension. A bacterial culture was grown in LB medium, and a viable count of the cells was obtained by colony summation. Dilutions of the culture were then prepared, and applied to the columns by 30 second centrifugation at 14,000 rpm. The flowthrough from the columns was then plated on ampicillin selective agar plates, and a viable cell count was obtained. It was found from this procedure that up to 96% of viable cells were either retained on the column, or were sheared as a result of their passage through the column and their interaction with the sharp particles of silicon carbide. Thus, silicon carbide columns can be used to remove and/or destroy viable bacterial cells from a liquid.
Figure 5 is a graph showing the number of viable cells present in the flowthrough after passing increasing amounts of bacterial cells through a silicon carbide column.
In another embodiment of the preferred invention, a silicon carbide slurry was used to remove bacteria from a liquid, in order to eliminate the sheer stress caused by centrifugation using a column format. Bacterial cells harbouring plasmid DNA
were cultivated to a specific optical density. A viable count of the cells was obtained by colony enumeration, and 10 fold dilutions of cells were applied to separate test tubes that contained lg SiC. The bacterial cells were mixed with the resin by gentle inversion for 30 seconds whereupon the resin was allowed to settle. After 15 minutes of settling, samples were then taken from the test tubes, diluted, and plated onto 3o ampilcillin selective agar plates. A viable count of the cells was then tabulated. It was found that the percentage of cells that were being retained and/or damaged by the resin in some manner is between 92 and 98%. Thus, silicon carbide slurry can be
-15-used to remove bacteria from a fluid such as water. The slurry could then be autoclaved or treated with chemicals in order to destroy the bacteria.
Alternatively, a series of wash steps could be performed in order to remove the bacteria from the resin.
The resulting wash liquid could then be treated to destroy the bacteria, and the slurry would then be regenerated and could be used again.
Figure 6 is a graph depicting bacterial removal from a suspension of bacterial cells using a slurry containing 1 gram of silicon carbide. It was found that the slurry was able to remove between 92 and 98% of bacterial cells.
While these examples and embodiments have demonstrated the removal of one adventitious agent at a time using silicon carbide, it should be apparent to those skilled in the art that variations and modifications of these methods may be made without departing from the invention and be used to remove combinations of adventitious materials from fluids. The invention includes all such variations and modifications as fall within the scope of the appended claims.
Alternatively, a series of wash steps could be performed in order to remove the bacteria from the resin.
The resulting wash liquid could then be treated to destroy the bacteria, and the slurry would then be regenerated and could be used again.
Figure 6 is a graph depicting bacterial removal from a suspension of bacterial cells using a slurry containing 1 gram of silicon carbide. It was found that the slurry was able to remove between 92 and 98% of bacterial cells.
While these examples and embodiments have demonstrated the removal of one adventitious agent at a time using silicon carbide, it should be apparent to those skilled in the art that variations and modifications of these methods may be made without departing from the invention and be used to remove combinations of adventitious materials from fluids. The invention includes all such variations and modifications as fall within the scope of the appended claims.
-16-
Claims (17)
1. A method for removing adventitious materials from a fluid, comprising passing said fluid through a column containing chromatography medium consisting of silicon carbide, wherein the adventitious materials are at least one of endotoxins, prions, viruses, bacteria, or any combination thereof, and the fluid comprises water, buffers, aqueous solutions or biological preparations of nucleic acids or proteins, or any combination thereof.
2. A method for removing adventitious materials from a fluid, comprising passing said fluid through a filter bed consisting of silicon carbide, wherein the adventitious materials are at least one of endotoxins, prions, viruses, bacteria, or any combination thereof, and the fluid comprises water, buffers, aqueous solutions or biological preparations of nucleic acids or proteins, or any combination thereof.
3. A method for removing adventitious materials from a fluid, comprising contacting said fluid containing adventitious materials with silicon carbide in the form of a slurry, wherein the adventitious materials are at least one of endotoxins, prions, viruses, bacteria, or any combination thereof, and the fluid comprises water, buffers, aqueous solutions or biological preparations of nucleic acids or proteins, or any combination thereof.
4. The method of any one of claims 1 to 3, wherein the adventitious materials bind to the silicon carbide and the remaining fluid is collected for use in other applications.
5. The method of claim 4, wherein the silicon carbide with the bound adventitious materials is treated with heat to inactivate the adventitious materials.
6. The method of claim 4, wherein the silicon carbide with the bound adventitious materials is treated with chemicals to inactivate the adventitious materials.
7. The method of claim 6, wherein the chemicals include a strong acid and base treatment.
8. The method of claim 7, wherein the silicon carbide with bound adventitious materials is washed with 1M HC1 followed by a washing with 1M NaOH.
9. The method of claim 4, further comprising the step of washing the silicon carbide using at least one liquid, wherein the bound adventitious materials are eluted from the silicon carbide and the silicon carbide is simultaneously regenerated.
10. The method of claim 9, wherein the eluted adventitious materials are treated with heat to inactivate the adventitious materials.
11. The method of claim 9, wherein the eluted adventitious materials are treated with chemicals to inactivate the adventitious materials.
12. The method of any one of claims 1 to 3, wherein nucleic acid or protein binds to the silicon carbide and the adventitious agent remains unbound and is removed in the flowthrough.
13. The method of claim 12, wherein the bound nucleic acid or protein is eluted from the silicon carbide into a desired fluid to be used in other applications.
14. The method of claim 12, wherein the flowthrough containing the adventitious materials is treated with heat in order to inactivate the adventitious materials.
15. The method of claim 12, wherein the flowthrough containing the adventitious materials is treated with chemicals in order to inactivate the adventitious materials.
16. The method of any one of claims 1-15, wherein the adventitious materials are bacteria and the bacteria are reduced by at least 90%.
17. The method of any one of claims 1-15, wherein the adventitious materials are endotoxins and wherein the endotoxins are reduced by at least 90%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2570956A CA2570956C (en) | 2006-12-12 | 2006-12-12 | Method of using silicon carbide for removal of adventitious agents |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2570956A CA2570956C (en) | 2006-12-12 | 2006-12-12 | Method of using silicon carbide for removal of adventitious agents |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2570956A1 CA2570956A1 (en) | 2008-06-12 |
CA2570956C true CA2570956C (en) | 2014-04-01 |
Family
ID=39521246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2570956A Active CA2570956C (en) | 2006-12-12 | 2006-12-12 | Method of using silicon carbide for removal of adventitious agents |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2570956C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9488625B2 (en) | 2010-12-15 | 2016-11-08 | Baxalta GmbH | Purification of factor VIII using a conductivity gradient |
WO2013028330A2 (en) * | 2011-08-19 | 2013-02-28 | Emd Millipore Corporation | Methods of reducing level of one of more impurities in a sample during protein purification |
-
2006
- 2006-12-12 CA CA2570956A patent/CA2570956C/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2570956A1 (en) | 2008-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7431842B2 (en) | Method of using silicon carbide for removal of adventitious agents | |
JP6956824B2 (en) | Methods for separating biopolymer units and viruses from liquids | |
TWI412394B (en) | Purification of proteins | |
CA2361545C (en) | Purification of biological substances | |
US6139746A (en) | Method and apparatus for purification of biological substances | |
US9441011B2 (en) | Method for purification of antibody using porous membrane having amino group and alkyl group both bound to graft chain immobilized on porous substrate | |
JP2013051970A (en) | Medium for membrane ion exchange chromatography | |
WO2005083080A1 (en) | Plasmid purification | |
CA2570956C (en) | Method of using silicon carbide for removal of adventitious agents | |
Ostreicher et al. | Charge-modified filter media | |
Machado et al. | Evaluation of a chitosan membrane for removal of endotoxin from human IgG solutions | |
RU2332247C1 (en) | Method of immunoglobulin purification (versions) | |
US20220040641A1 (en) | Multiple membrane separation capsule | |
JP2009042074A (en) | Adsorption carrier and manufacturing method of same | |
WO2023170028A1 (en) | Method for reducing endotoxin levels in nucleic acid purification | |
KR20210148246A (en) | filtration | |
JP2023104650A (en) | Method for separating and purifying extracellular vesicles | |
Banerjee | Isolation and purification of enzymes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |